However, it is important to highlight that for the T1-T2 stage and CMS4, while the distinction did not reach statistical significance, a discernible trend was still observable.
← all excerpts
Integrative analysis reveals a four-gene signature for predicting survival and immunotherapy response in colon cancer patients using bulk and single-cell RNA-seq data.
1
—
—